3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Virus Diseases
1
Tumor Virus Infections
1
Squamous Cell Carcinoma of Head and Neck
1
Pharyngeal Diseases
1
Papillomavirus Infections
1
Otorhinolaryngologic Neoplasms
1
Otorhinolaryngologic Diseases
1
Oropharyngeal Neoplasms
1
Neoplasms, Squamous Cell
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Head and Neck Neoplasms
1
DNA Virus Infections
1
Carcinoma, Squamous Cell
1
Carcinoma
1
Interventions
Cisplatin
14
Radiotherapy, Intensity-Modulated
12
pembrolizumab
7
Radiotherapy
7
Magnetic Resonance Spectroscopy
7
Specimen Handling
6
Platinum
6
Carboplatin
6
Radiation
5
1,2-diaminocyclohexaneplatinum II citrate
5
Taxes
3
Surveys and Questionnaires
3
Paclitaxel
3
Nivolumab
3
Fluorodeoxyglucose F18
3
Biopsy
3
durvalumab
2
Drug Therapy
2
prednylidene
1
peposertib
1
niraparib
1
exifone
1
entinostat
1
dostarlimab
1
deltacortene
1
dehydroftorafur
1
cemiplimab
1
bintrafusp alfa protein, human
1
atezolizumab
1
X-Rays
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Oropharyngeal Neoplasms
×
Nimorazole
×
Clear all
NCT04124198
2025-12-31
QoLATI
Rigshospitalet, Denmark
Phase NA
Active not recruiting
138 enrolled